15 January 2004 : Original article
In-Vitro Test and Mathematical Modeling on The Controlled-Release Behavior of Indomethacin from PLA-PEO Nanospheres
Y S Jo, M Kim, D K Kim, C J Kim, J K Jeong, K J Kim, M MuhammedAnn Transplant 2004; 9(1A): 96-100 :: ID: 15646
Abstract
Objectives: Drug delivery systems (DDS) have been focused on as the most effective way to administer highly insoluble drug under physiological conditions to the targeted site in a controlled manner. Here, we report the synthesis of poly (lactic acid-co-ethylene oxide) (PLA-PEO), fabrication of PLA-PEO amphiphilic DDS and investigations of releasing behaviours of indomethacin as a model drug.
Methods: Sn (II) 2-ethylhexanoate was used to polymerize poly (L-lactide) (PLLA) with poly (ethylene glycol) (PEG) via ring-opening polymerization (ROP). The emulsion/evaporation technique was used to produce amphiphilic nanospheres and resulted in a homogeneous size distribution with a low polydispersity index. Under physiologically similar conditions, an in vitro test was conducted via a dialysis method in phosphate saline buffer solution (PBS).
Results: 1H-NMR, DSC and XRD analysis indicated that PLLA-PEO copolymer was successfully synthesized. Moreover, a QELS particle sizer
showed the spheres were well-defined with a narrow distributional character. As for the in vitro experiments, the releasing behaviours of
indomethacin were well explained by two different types of mathematical models constructed, including diffusion and dissolution models.
Conclusions: It was confirmed that key parameters such as volumetric ratio (Vr) between the organic and aqueous phases, the interaction parameter (Kp), and encapsulation efficiency (EE), affected to the overall characteristics of the controlled-release of the encapsulated drug. As the system had higher Vr value, the releasing profile tended to move toward the dissolution model, so that overall efficiencies (ζ) were evaluated to optimize the DDS for a specific type of drug or materials under consideration of various parameters to be manipulated.
Keywords: Drug Delivery Systems, Poly (Lactide), in vitro, Controlled-Release, Indomethacin, Block Copolymer, Biocompatible Materials
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860